Lifecore Biomedical, Inc.
LFCR · NASDAQ
5/25/2025 | 5/26/2024 | 5/28/2023 | 5/29/2022 | |
|---|---|---|---|---|
| Market Cap | $233,983 | $171,264 | $237,867 | $290,829 |
| - Cash | $8,265 | $8,462 | $19,091 | $1,643 |
| + Debt | $130,823 | $130,360 | $112,740 | $247,783 |
| Enterprise Value | $356,541 | $293,162 | $331,516 | $536,969 |
| Revenue | $128,867 | $128,261 | $103,269 | $111,270 |
| % Growth | 0.5% | 24.2% | -7.2% | – |
| Gross Profit | $40,298 | $41,850 | $27,985 | $39,066 |
| % Margin | 31.3% | 32.6% | 27.1% | 35.1% |
| EBITDA | -$8,812 | $35,604 | -$33,170 | $12,844 |
| % Margin | -6.8% | 27.8% | -32.1% | 11.5% |
| Net Income | -$38,717 | $12,013 | -$99,563 | -$116,715 |
| % Margin | -30% | 9.4% | -96.4% | -104.9% |
| EPS Diluted | -1.27 | 0.33 | -3.32 | -3.97 |
| % Growth | -484.8% | 109.9% | 16.4% | – |
| Operating Cash Flow | -$206 | $257 | -$17,441 | -$22,593 |
| Capital Expenditures | -$13,415 | -$18,395 | -$21,482 | -$29,940 |
| Free Cash Flow | -$13,621 | -$18,138 | -$38,923 | -$52,533 |